| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 688.11× | 688.11× | 525.90× | 428.32× | 436.58× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.37× | 0.51× | 0.69× | 0.85× | 0.85× | ||
| 0.01× | 0.01× | 0.01× | 0.01× | 0.01× | ||
| 0.04× | 0.04× | 0.85× | 0.10× | −0.19× | ||
| 0.09× | 0.09× | 1.73× | −0.07× | 0.27× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 436.58 | 428.32 | 525.90 | 688.11 | 688.11 | |
| Working Capital Turnover | 0.85 | 0.85 | 0.69 | 0.51 | 0.37 | |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Cash Conversion (CFO/Net Income) | -0.19 | 0.10 | 0.85 | 0.04 | 0.04 | |
| CFO/EBITDA | 0.27 | -0.07 | 1.73 | 0.09 | 0.09 |